Cover Letter 投稿信及写法1、 什么是 cover letter？cover letter 指的是投稿信2、 cover letter 的内容主要包括那些？应该简述所投稿件的核心内容、主要发现和意义，拟投期刊，对稿件处理有无特殊要求等（如“not to review” list） 。另外，请附上主要作者的中文姓名、通讯地址、电话、传真和 e-mail 地址。此外有的杂志要求推荐几位审稿人及其联系方式。以及谁已经阅读过该文（当然是牛人） 。我投的那个杂志是要求说明你论文研究的意义，以及与这个杂志的相关性，另外还有的可能要写明你没有一搞多投等。此外临床实验要求写明符合伦理学要求。3、 如何写 cover letter？各个杂志的具体要求是不一样的，在杂志的 guide for authors 一般会有要求。如果没有具体的要求，大家可按照通用要求处理。4、常用模板：（1）Dear Mr. *,1. The work described has not been submitted elsewhere for publication, in whole or in part, and all the authors listed have approved the manuscript that is enclosed. 2. I have read and have abided by the statement of ethical standards for manuscripts submitted to Neuroscience.Kind regards. Your sincerely, 通讯作者 （2） Dear Dr. 主编 name: We submit our manuscript entitled 文章 title to 杂志名 for publication. 接着简单介绍你文章的主要创新点和意义，不易过多，但要突出新意和关键点。All authors have seen the manuscript and approved to submit to your journal. Thank you very much for your attention and consideration. Sincerely yours, 通讯作者 （3） Dear Dr. 主编 name: We submit our manuscript entitled 文章 title to 杂志名 for publication. 接着简单介绍你文章的主要创新点和意义，不易过多，但要突出新意和关键点。All authors have seen the manuscript and approved to submit to your journal. Thank you very much for your attention and consideration. Sincerely yours, 通讯作者（4） Dear Prof. Gil: This is a manuscript by*and *entitled “.”. It is submitted to be considered for publication as a “.” in your journal. This paper is new. Neither the entire paper nor any part of its content has been published or has been accepted elsewhere. It is not being submitted to any other journal. We believe the paper may be of particular interest to the readers of your journal as it . Correspondence should be addressed to *at the following address, phone and fax number, and email address: .Thanks very much for your attention to our paper. Sincerely yours, * 5、 例文：下面例文都来自丁香园战友，在此一并感谢。Dear Editors: On behalf of my co-authors, I am submitting the enclosed material “ TITLE ” for possible publication in JOURNAL. We certify that we have participated sufficiently in the work to take public responsibility for the appropriateness of the experimental design and method, and the collection, analysis, and interpretation of the data. We have reviewed the final version of the manuscript and approve it for publication. To the best of our knowledge and belief, this manuscript has not been published in whole or in part nor is it being considered for publication elsewhere. Best Regards. Yours Sincerely, NAME,ADRESS,EMAIL,FAX Dear Dr Regino Perez-Polo： Enclosed are a manuscript by su jian, yang kun, chen zhihua Su jian titled“Hypothermia after Acute Ischemic Stroke ”It is submitted to be considered for publication as a“review in your journal.This paper is-Neither the entire paper nor any part of its content has been published or has been accepted elsewhereIt is not being submitted to any other journalWe believe the paper may be of particular interest to the readers of your journal. Correspondence and phone calls about the paper should be directed to Su jian at the following address,phone and fax number,and e-mail address： Su jian Institute:, Adress: Tel： Fax: E-mail： Thanks very much for your attention to our paper Sincerely yours， Su jian Dear Editor, We would like to submit the enclosed manuscript entitled GDNF Acutely Modulates Neuronal Excitability and A-type Potassium Channels in Midbrain Dopaminergic Neurons, which we wish to be considered for publication in Nature Neuroscience. GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinsons disease. In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices. Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase. Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF. Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release. These results may also have implications in the treatment of Parkinsons disease. Due to a direct competition and conflict of interest, we request that Drs. XXX of Harvard Univ., and YY of Yale Univ. not be considered as reviewers. With thanks for your consideration, I amSincerely yours, Dear *. We would like to submit the enclosed manuscript entitled * , which we wish to be consideredfor publication in *journal. We believe that two aspects of this manuscript will make it interesting to general readers of *journal. First, *. Second, *. Further, *. Thank you very much your considering our manuscript for potential publ